Portugal, April 27 -- Portugal based ASTRAZENECA-PRODUTOS FARMACEUTICOS,LDA. has secured contract from Unidade Local De Saude Amadora/Sintra, E.P.E. for Acquisition Of Tremelimumab Iv 20Mg Ml 15 Sol Perf To Lab Astrazeneca For Ulsasi For The Year 2026. The value of the contract is worth 24096000 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....